Belantamab mafodotin Antibody, CAS [[2050232-20-5]], Unconjugated

Produktübersicht

• Artikelname: Belantamab mafodotin Antibody, CAS [[2050232-20-5]], Unconjugated
• Artikelnummer: BYT-ORB2279041
• Hersteller Artikelnummer: orb2279041
• Alternativnummer: BYT-ORB2279041-1,BYT-ORB2279041-10,BYT-ORB2279041-25,BYT-ORB2279041-5
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Konjugation: Unconjugated
• Alternative Synonym: ADCs, AntibodyDrugConjugates(ADCs), AntibodyDrugConjugates, AntibodyDrug Conjugates (ADCs), Antibody-Drug Conjugates, Belantamab mafodotin, Belantamab mafodotin-blm, GSK2857916, GSK-2857916, GSK 2857916

Produktbeschreibung

Belantamab mafodotin (GSK2857916) is a BCMA-targeting antibody-drug conjugate for multiple myeloma research. It promotes immune cell activity within tumors and inhibits tumor progression, making it applicable for both in vitro mechanistic studies and in vivo xenograft models of hematological malignancies.

Produkteigenschaften

• Konzentration: 7.98 mg/mL
• Molekulargewicht: 146.06 kDa
• Reinheit: 99.14% (May vary between batches)
• CAS Nummer: [2050232-20-5]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)